FP&A Specialist

Company OverviewSince its inception over a decade ago, CRISPR Therapeutics has transformed from a research-stage company advancing programs in the field of gene editing, to a company with a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular and rare diseases. The Nobel Prize-winning CRISPR science has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Bayer and Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California, and business offices in London, United Kingdom.Position SummaryOur Financial Planning & Analysis group is looking for an experienced FP&A Specialist to join the team. This position is a key role within the Finance group that will support various aspects of finance and accounting for the company. This role will serve as the Finance Business Partner for our G&A pillar. As well as ad hoc financial support across all R&D functions. The position requires a solid financial background combined with strong analytical skills. This is an excellent opportunity to further build one's finance skills by working with a high-performing, collaborative team while providing great exposure to all aspects of the Company's business.ResponsibilitiesFinance Business Partner for G&A FunctionsFinancial Analyst will have the ability to drive business decisions through effective analysis and communication with department ownersBuild and maintain reporting and dashboards to track key metrics, proactively address problems and opportunitiesPlay a critical role in the preparation of the annual budget and quarterly reforecastOwn analyses of actual results versus plan and key trends impacting the businessGather, organize, and validate financial data from various sources to ensure accuracy and integrityThe individual will also work closely with Accounting, assisting in the booking of journal entries and supporting the month-end closeManage program time tracking systemPartner cross functionally on ad-hoc projectsMinimum QualificationsUndergraduate degree in Accounting, Finance, or Economics. MBA preferred3-5+ years of relevant experience or advanced degree and 2+ years of relevant experienceHigh aptitude in Excel ModelingAbility to present financial information to a non-financial audience, excellent communication, interpersonal, and presentation skillsDetail-oriented and able to perform in a high-pressure environmentDemonstrated ability to work in a dynamic and rapidly changing environment and the flexibility to handle multiple priorities simultaneouslyStrong organizational skills with the ability to collaborate and partner across teamsPreferred QualificationsExperience in BiopharmaLife ScienceOracle experienceCompetenciesCollaborative - Openness, One TeamUndaunted - Fearless, Can-do attitudeResults Orientation - Delivering progress toward our mission. Sense of urgency in solving problems.Entrepreneurial Spirit - Proactive. Ownership mindset.CRISPR Therapeutics believes in fostering a dynamic workplace that balances remote work flexibility with the benefits of in-person interactions. Our employees work at least four days on-site, creating a collaborative work environment, where we cultivate mentorship opportunities, increase cross-functional communication and offer opportunities for our employees to connect.CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.To view our Privacy Statement, please click the following link:

Created: 2024-10-19